logo

For the Inventor, By the Inventor

San Carlos, CA, United States of America

Reimar C Bruening

This inventor holds 3 USPTO granted patents. Top assignee: Shaman Pharmaceuticals, Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reimar C Bruening. Retrieved from https://idiyas.com/inventor/reimar-c-bruening

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal3 out of 22 
 
Shaman Pharmaceuticals, Inc.
 patents

Years Active: 1997

Loading Chart...
3 patents (USPTO):Explore Patents
1. 5681829 - Class of phosphocholine derivatives having antifungal activity (1997-10-28),
2. 5629319 - Hypoglycemic agent from cryptolepis (1997-05-13),
3. 5628999 - Hypoglycemic agent from cryptolepis (1997-05-13),

Title: Reimar C Bruening: Innovator in Antifungal and Hypoglycemic Agents

Introduction

Reimar C Bruening is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antifungal and hypoglycemic properties. With a total of three patents to his name, Bruening's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents, Bruening has developed a class of phosphocholine derivatives that exhibit antifungal activity. Additionally, he has worked on hypoglycemic agents derived from Cryptolepis, specifically focusing on the use of extracts from Cryptolepis sanguinolenta. These extracts and quindoline alkaloids, such as quindoline and cryptolepine, are designed to treat both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.

Career Highlights

Reimar C Bruening is associated with Shaman Pharmaceuticals, Inc., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approaches have led to the creation of valuable therapeutic agents that address critical health issues.

Collaborations

Throughout his career, Bruening has collaborated with esteemed colleagues, including Donald E Bierer and Jian Luo. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Reimar C Bruening's contributions to the field of pharmaceuticals, particularly in antifungal and hypoglycemic agents, highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…